Results 41 to 50 of about 61,357 (186)

Staging of intrahepatic cholangiocarcinoma [PDF]

HepatoBiliary Surgery and Nutrition, 2017
Intrahepatic cholangiocarcinoma (ICC) comprises approximately 5-30% of primary liver tumors, however it has been increasing over the last several decades. Up to and including the 6th edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) edition staging system, ICC was staged the same as hepatocellular ...
Sean M, Ronnekleiv-Kelly, Timothy M, Pawlik   +1 more
openaire   +2 more sources

Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum lady

Journal of Family Medicine and Primary Care, 2019
Intrahepatic cholangiocarcinoma is an uncommon malignancy which usually occurs in the 7th decade. Here we present a postpartum patient with fever, hepatomegaly, and ascites, who was diagnosed to have metastatic intrahepatic cholangiocarcinoma.
Sohini Das, Manoj Job, Thomas Kodiatte, Ramya Iyadurai   +3 more
doaj   +1 more source

Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma [PDF]

Clinical and Molecular Hepatology, 2016
A bile duct lesion originating from intrahepatic bile ducts is generally regarded as an incidental pathologic finding in liver specimens. However, a recent study on the molecular classification of intrahepatic cholangiocarcinoma has focused on the ...
Kyoung-Bun Lee
doaj   +1 more source

Pathology of intrahepatic cholangiocarcinoma [PDF]

HepatoBiliary Surgery and Nutrition, 2017
Intrahepatic cholangiocarcinoma (iCC) is a primary carcinoma of the liver with increasing significance and major pathogenic, clinical and therapeutic challenges. Classically, it arises from malignant transformation of cholangiocytes bordering small portal bile duct (BD) to second-order segmental large BDs. It has three major macroscopic growth pattern [
Vijgen, Sandrine Elisabeth V, Terris, Benoit, Rubbia-Brandt, Laura   +2 more
openaire   +4 more sources

Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma

, 2018
Background: Intrahepatic cholangiocarcinoma with hepatic hilus involvement has been either classified as intrahepatic cholangiocarcinoma or hilar cholangiocarcinoma.
Luca Aldrighetti, Feng Shen, Aldrighetti, Luca, Maithel, SK, Koerkamp, B Groot, Timothy M. Pawlik, Popescu, Irinel, Yi Lv, Lv, Yi, Soubrane, O, Weiss, M, Poultsides, George A, Groot Koerkamp, B; id_orcid, Poultsides, GA, Xu-Feng Zhang, Zhang, XF, Qinyu Chen, Carlo Pulitano, Weiss, Matthew, Martel, Guillaume, Beal, EW, Lv, Y, Guglielmi, Alfredo, Pulitano, C, Pawlik, Timothy M, Fabio Bagante, Bagante, F, Martel, G, Guglielmi, A, Popescu, I, Maithel, Shishir K, Bagante, Fabio, Olivier Soubrane, Bauer, Todd W, Marques, Hugo P, Soubrane, Olivier, Aldrighetti, L, B. Groot Koerkamp, Beal, Eliza W, Guillaume Martel, Eliza W. Beal, Alfredo Guglielmi, Itaru, Endo, Pawlik, TM, Groot Koerkamp, B, Irinel Popescu, Shen, F, Zhang, Xu-Feng, Pulitano, Carlo, Shen, Feng, George A. Poultsides, Itaru, E, Chen, Qinyu, Hugo P. Marques, Shishir K. Maithel, Todd W. Bauer, Chen, QY, Marques, HP, Bauer, TW, Matthew Weiss, Endo Itaru   +60 more
core   +2 more sources

Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma

Technology in Cancer Research & Treatment, 2021
Cholangiocarcinoma is a general term for intrahepatic and extrahepatic malignant tumors deriving in the biliary system. According to the location, it is divided into intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma.
Fan-li Zeng MD, Jing-fang Chen BD
doaj   +1 more source

Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma [PDF]

, 2023
Background: Most data on the treatment and outcomes of intrahepatic cholangiocarcinoma (iCCA) derives from expert centers. This study aimed to investigate the treatment and outcomes of all patients diagnosed with iCCA in a nationwide cohort.
Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG)
core  

Intrahepatic Cholangiocarcinoma Initially Presented as a Distant Metastatic Lymph Node without Demonstrable Hepatic Mass: A Case Report

대한영상의학회지, 2017
This report describes a rare case of intrahepatic cholangiocarcinoma, initially presented as a distant metastatic lymph node without demonstrable hepatic mass, in a 37-year-old man. Initially, a solitary cystic mass around the common hepatic artery was
Lyo Min Kwon, Hong Il Ha, Min-Jeong Kim, Kwanseop Lee, Mi Jung Kwon   +4 more
doaj   +1 more source

Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma. [PDF]

, 2015
Intrahepatic cholangiocarcinomas are the second most common primary liver malignancies with an increasing incidence over the past decades. Due to a lack of early symptoms and their aggressive oncobiological behavior, the diagnostic approach is ...
Bartella, Isabel, Dufour, Jean-François
core   +1 more source

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma

Frontiers in Pharmacology, 2022
Background: Lenvatinib combined with a PD-1 inhibitor has obtained a satisfactory antitumor effect in several solid tumors. However, the efficacy and tumor response of lenvatinib with a PD-1 inhibitor in advanced intrahepatic cholangiocarcinoma still ...
Lulu Xie, Jingzheng Huang, Linling Wang, Wenrui Ren, Hao Tian, Anhong Hu, Jun Liang, Yuqing Jiao, Yali Li, Qunfang Zhou, Wenjing Zhang   +10 more
doaj   +1 more source